In this Review, we provide a comprehensive overview of methods and materials aimed at modulating airway mucus for protection and pulmonary drug delivery through the mucus barrier (Table 1)
Alvarez, F
The method of embodiment 53, wherein the composition comprises between about 0.01% to about 20% by weight of the carbomer, about 0.01% to about 15% by weight of the carbomer, about 0.01% to about 10% by weight of the carbomer, about 0.01% to about 7% by weight of the carbomer, about 0.01% to about 5% by weight of the carbomer, about 0.01% to about 3% by weight of the carbomer, about 0.01% to about 2% by weight of the carbomer, or about 0.01% to about 1% by weight of the carbomer
The 2026 WADA Prohibited List, which classifies BPC-157 in the S0 Unapproved Substances category, applies to competitive sport contexts and is separate from FDA dietary supplement oversight
Coffee can reduce the drugs absorption in the digestive tract by up to 55%